Оценка на веществата - CoRAP

Оценка на веществата - CoRAP

Оценка на веществата - CoRAP

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
Suspected PMT/vPvM: Potentially Persistent, Mobile and Toxic/very Persistent and very Mobile.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 22 Март 2024. Database contains 402 unique substances/entries.
Filter the list
Initial grounds for concern:

The List does not contain any Substances.
 
947-768-1
-
2025
Netherlands
Suspected Mutagenic
Other hazard based concern
Exposure of workers
Wide dispersive use
Not started
Details
941-303-6
-
2026
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Not started
Details
939-505-4
-
2023
France
Potential endocrine disruptor
Exposure of environment
Ongoing
Details
938-828-8
-
2021
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
931-745-8
-
2014
Sweden
Suspected PBT/vPvB
Exposure of environment
High RCR
Follow-up
Details
931-700-2
-
2026
France
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Not started
Details
931-384-6
-
2013
Slovenia
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Concluded
Details
931-292-6
308062-28-4
Ireland
Suspected Reprotoxic
Other hazard based concern
Withdrawn
Details
931-274-8
-
2014
Slovenia
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
926-564-6
-
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
915-730-3
-
2017
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Information requested
Details
907-745-9
-
2015
Belgium
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
906-484-8
-
2015
Slovenia
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-241-0, 906-390-7
-
Italy
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Withdrawn
Details
905-806-4
-
2015
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
905-588-0
-
Germany
Suspected Reprotoxic
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Withdrawn
Details
905-562-9
-
Germany
Suspected Reprotoxic
Suspected Sensitiser
Other hazard based concern
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Withdrawn
Details
905-459-9
-
2025
France
Suspected Reprotoxic
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Not started
Details
810-801-4
-
2015
Netherlands
Suspected CMR
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
809-930-9
1330-78-5
2014
Netherlands
Suspected PBT/vPvB
Other hazard based concern
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
807-935-0
1244733-77-4
2022
Denmark
Suspected Carcinogenic
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Cumulative exposure
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
800-353-8
1379524-06-7
2016
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
High RCR
Wide dispersive use
Concluded
Details
701-463-8
-
2025
Spain
Suspected PBT/vPvB
Consumer use
Exposure of environment
Wide dispersive use
Not started
Details
701-394-3
1782069-81-1
2020
Germany
Potential endocrine disruptor
Concluded
Details
701-385-4
-
2021
France
Suspected Mutagenic
Suspected PBT/vPvB
High (aggregated) tonnage
Information requested
Details
701-339-3
-
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
701-337-2
-
2020
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-276-1
-
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Withdrawn
Details
701-266-7
-
2018
Czech Republic
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
701-263-0
-
2020
Denmark
Potential endocrine disruptor
Concluded
Details
701-251-5
-
2013
Netherlands
CMR
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
701-246-8
-
2025
Spain
Suspected PBT/vPvB
Consumer use
Exposure of environment
Wide dispersive use
Not started
Details
701-057-0
-
Germany
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Withdrawn
Details
701-029-8
-
Estonia
CMR
Sensitiser
Consumer use
Wide dispersive use
Withdrawn
Details
701-028-2
-
2013
France
Suspected PBT/vPvB
Consumer use
Exposure of sensitive populations
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
700-992-1
-
2014
Norway
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
700-989-5
-
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
show/hide
Phenol, methylstyrenated EC / List no: 270-966-8 | CAS no: 68512-30-1
700-960-7
-
2012
Denmark
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
700-604-0
947701-81-7
Finland
Suspected PBT/vPvB
Consumer use
Withdrawn
Details
700-579-6
-
2017
Netherlands
Suspected PBT/vPvB
Wide dispersive use
Concluded
Details
700-427-9
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Concluded
Details
700-403-8
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Concluded
Details
700-323-3
908020-52-0
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
700-242-3
62037-80-3
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
700-183-3
52299-25-9
2018
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Concluded
Details
700-161-3
-
2013
Netherlands
Suspected PBT/vPvB
Ongoing
Details
629-767-5
1228186-18-2
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
629-732-4
1224966-13-5
2015
Lithuania
Sensitiser
Exposure of sensitive populations
Exposure of workers
Concluded
Details
629-661-9
83834-59-7
2016
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
627-872-0
1514-82-5
2019
Spain
Suspected Reprotoxic
Potential endocrine disruptor
Concluded
Details
627-083-1
244235-47-0
2015
Spain
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
622-542-2
3891-98-3
Austria
Suspected Mutagenic
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Withdrawn
Details
609-946-4
41637-38-1
Germany
Suspected PBT/vPvB
Exposure of environment
Withdrawn
Details
1 - 2.5 moles ethoxylated
500-209-1
68412-54-4
2016
United Kingdom
Potential endocrine disruptor
Other hazard based concern
High (aggregated) tonnage
Concluded
Details
1 - 4.5 moles propoxylated
500-097-4
37353-75-6
2013
Denmark
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
1 - 4.5 moles ethoxylated
500-082-2
32492-61-8
2026
France
Suspected Mutagenic
Potential endocrine disruptor
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Not started
Details
484-470-6
623-40-5
2022
Germany
Suspected Carcinogenic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
484-450-7
-
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
484-410-9
-
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
480-310-4
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
473-390-7
-
2016
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
468-710-7
754-12-1
2012
Germany
Other hazard based concern
Exposure of environment
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
WASOX-VMAC2
458-680-3
797751-44-1
2019
Spain
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
448-020-2
-
2013
Slovakia
CMR
Suspected PBT/vPvB
High RCR
Concluded
Details
447-780-2
-
2014
Estonia
Suspected CMR
Suspected PBT/vPvB
Exposure of environment
Exposure of workers
Concluded
Details
444-340-1
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
435-790-1
297730-93-9
2018
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Conclusion under preparation
Details
432-520-2
232938-43-1
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Withdrawn
Details
432-240-0
12056-51-8
2017
France
Carcinogenic
Exposure of workers
Information requested
Details
430-050-2
-
2017
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
429-320-2
24748-23-0
2019
Netherlands
PBT/vPvB
Information requested
Details
428-970-4
13595-25-0
2014
Belgium
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Concluded
Details
422-270-2
163702-08-7
2019
Spain
Suspected PBT/vPvB
Ongoing
Details
CASSIFFIX
422-040-1
426218-78-2
2016
Spain
Suspected PBT/vPvB
Exposure of environment
High RCR
Concluded
Details
CD 28-0132; IRGALUBE 232
421-820-9
192268-65-8
2025
Netherlands
Suspected PBT/vPvB
Not started
Details
421-450-8
154702-15-5
2015
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
ADDITIV 104
412-780-3
1380226-46-9
France
Suspected PBT/vPvB
Concluded
Details
D-8; DD-8
405-520-5
95235-30-6
2025
Belgium
Potential endocrine disruptor
Other exposure/risk based concern
Not started
Details
BENZYL-2-NAPHTHYLETHER; BETA-NAPHTHYLBENZYLETHER (BON); BNE; BON; NIPAFAX BNE; SENSLON-50; ZO-1
405-490-3
613-62-7
2012
Czech Republic
Other hazard based concern
High (aggregated) tonnage
Concluded
Details
405-420-1
-
2021
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
CIS/TRANS-TIMO; FLOROL; FLOROSA
405-040-6
63500-71-0
2012
Spain
High RCR
Wide dispersive use
Concluded
Details
IRGANOX L 118
404-800-4
118832-72-7
2014
Germany
Suspected PBT/vPvB
Concluded
Details
404-740-9
115895-09-5
2016
Slovenia
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
BENZTRIAZOL UV ABSORBER BUK 4499; BUK 4499; UV ABSORBER BUK 4499
403-080-9
92484-48-5
2023
Spain
Suspected PMT/vPvM
Other hazard based concern
Consumer use
Cumulative exposure
Exposure of environment
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
ROBAC AS/100
403-030-6
137398-54-0
Belgium
Suspected PBT/vPvB
Concluded
Details
X4261
401-850-9
255881-94-8
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
400-370-7
6196-98-1
2021
Finland
Suspected PBT/vPvB
Exposure of environment
Follow-up
Details
310-154-3
121158-58-5
2018
Germany
Potential endocrine disruptor
Concluded
Details
309-912-6
101357-15-7
2019
Germany
Suspected PBT/vPvB
Concluded
Details
308-662-5
98171-53-0
2023
France
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of workers
Ongoing
Details
306-832-3
97416-84-7
2017
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
300-340-2
93925-38-3
2023
Sweden
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of sensitive populations
Exposure of workers
Wide dispersive use
Ongoing
Details
295-835-2
92129-33-4
2015
Italy
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
287-477-0
85535-85-9
2012
United Kingdom
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
287-401-6
85507-79-5
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details
284-660-7
84961-70-6
2014
Italy
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
284-366-9
84852-53-9
2012
Sweden
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Follow-up
Details
284-325-5
84852-15-3
2014
Spain
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Conclusion under preparation
Details
283-044-5
84539-55-9
2021
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Concluded
Details
278-355-8
75980-60-8
Sweden
Reprotoxic
Potential endocrine disruptor
Withdrawn
Details

Export search results to: